When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Alcohol use disorder

Last reviewed: 19 Mar 2025
Last updated: 18 Sep 2024

Summary

Definition

Anamnesis y examen

Principales factores de diagnóstico

  • withdrawal
  • tolerance
  • increased/decreased liver size, jaundice, ascites
Todos los datos

Otros factores de diagnóstico

  • insomnia
  • erectile dysfunction
  • nicotine use disorder
  • gastrointestinal distress
  • muscle cramps, pain, tenderness, altered sensory perception
  • hypertension and tachycardia
  • impaired nutritional status
  • broad-based gait
Todos los datos

Factores de riesgo

  • family history of alcohol use disorder
  • antisocial behavior (premorbid)
  • high trait anxiety level
  • lack of facial flushing on exposure to alcohol
  • low responsivity to the effects of alcohol
  • history of gastric bypass
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • diagnostic interview
  • alcohol level (breath and blood)
  • Clinical Institute Withdrawal Assessment for Alcohol, revised (CIWA-Ar)
Todos los datos

Pruebas diagnósticas que deben considerarse

  • carbohydrate-deficient transferrin (CDT)
  • gamma glutamyl transpeptidase (gamma-GT), alanine aminotransferase (ALT), aspartate aminotransferase (AST)
  • CBC
  • urinary ethyl glucuronide
Todos los datos

Algoritmo de tratamiento

En curso

at-risk drinking

alcohol use disorder: nonpregnant adult with no concurrent opioid use or mental health diagnosis

alcohol use disorder: nonpregnant adult with concurrent opioid use

alcohol use disorder: nonpregnant adult with concurrent mental health diagnosis

alcohol use disorder: nonpregnant adolescent

alcohol use disorder: pregnant

Colaboradores

Autores

Elisabeth Poorman, MD, MPH

Assistant Professor of Medicine

Department of Medicine

University of Illinois Chicago

Chicago

IL

Divulgaciones

EP declares that she has no conflicting interests.

Marlene Martin, MD

Associate Professor of Clinical Medicine

Director, Addiction Care Team

San Francisco General Hospital

University of California, San Francisco

San Francisco

CA

Divulgaciones

MM is a board member for the National Harm Reduction Coalition and has done consultancy work for the Society of Hospital Medicine.

Sarah Messmer, MD

Assistant Professor of Clinical Medicine and Pediatrics

University of Illinois Chicago

Chicago

IL

Divulgaciones

SM declares that she has no conflicting interests.

Agradecimientos

Dr Elisabeth Poorman, Dr Marlene Martin, and Dr Sarah Messmer would like to gratefully acknowledge Dr Colin Drummond, Dr Julie R. Pittman, Dr Philip H. Chung, Dr Robert M. Swift, and Dr Lorenzo Leggio, previous contributors to this topic.

Divulgaciones

CD, JRP, PHC, and RMS declare that they have no competing interests. LL is an author of a reference cited in this topic.

Revisores por pares

Paul S. Haber, MD

Royal Prince Alfred Hospital and Discipline of Medicine

University of Sydney

Sydney

Australia

Divulgaciones

PSH is an author of a reference cited in this topic.

Roberta Agabio, MD

Bernard B. Brodie Department of Neuroscience

University of Cagliari

Cagliari

Italy

Divulgaciones

RA is an author of a number of references cited in this topic.

  • Diferenciales

    • Other psychiatric disorders
    • Other substance use disorders (especially sedatives)
    Más Diferenciales
  • Guías de práctica clínica

    • Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR)
    • International statistical classification of diseases and related health problems, 11th ed. (ICD-11)
    Más Guías de práctica clínica
  • Folletos para el paciente

    Alcohol-use disorder

    Más Folletos para el paciente
  • Calculadoras

    Alcohol Consumption Screening AUDIT Questionnaire

    Más Calculadoras
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad